Eisai Co., Ltd.
4523・Prime Market・Pharmaceuticals
Eisai Co., Ltd.4523
Eisai Co., Ltd.4523
Reference Indicators
Market Cap
13,072¥100M
P/E (Forecast)
24.2x
P/B
1.4x
Dividend Yield (Forecast)
3.57%
ROE
4.3%
EV/EBITDA
12.7x
Financial Summary
Unit: ¥M
| Item | 2022Mar 2022 | 2023Mar 2023 | 2024Mar 2024 | 2025Mar 2025 | 2026Mar 2026 |
|---|---|---|---|---|---|
Net Sales | 756,226 | 744,402 | 741,751 | 789,400 | 825,378 |
Cost of Sales | 174,831 | 177,837 | 155,333 | 168,807 | 191,223 |
Gross Profit | 581,395 | 566,566 | 586,417 | 620,593 | 634,155 |
SG&A Expenses | 366,430 | 358,292 | 374,421 | 407,983 | 435,285 |
Operating Income | 53,750 | 40,040 | 53,408 | 54,378 | 44,138 |
Pre-tax Income | 54,458 | 45,012 | 61,823 | 61,065 | 50,999 |
Income Taxes | 8,741 | -11,824 | 18,040 | 13,007 | 10,478 |
Net Income | 47,954 | 55,432 | 42,406 | 46,432 | 38,558 |
EBITDA | 92,148 | 80,021 | 92,806 | 94,284 | 83,688 |
Gross Margin | 76.9% | 76.1% | 79.1% | 78.6% | 76.8% |
Operating Margin | 7.1% | 5.4% | 7.2% | 6.9% | 5.3% |
ROA | 3.9% | 4.4% | 3.0% | 3.3% | 2.7% |
ROE | 6.4% | 6.9% | 4.8% | 5.5% | 4.3% |
Segment Performance
Unit: ¥M
2026
| Segment | Net Sales | Operating Income | Operating Margin |
|---|---|---|---|
| その他 | 14,599 | 4,508 | 30.9% |
| 日本 | 229,238 | 72,979 | 31.8% |
| アメリカス | 300,440 | 174,375 | 58.0% |
| 中国 | 130,745 | 59,312 | 45.4% |
| EMEA | 81,532 | 30,412 | 37.3% |
| イーストアジア・グローバルサウス | 68,823 | 30,245 | 43.9% |